CA9 and nasopharyngeal carcinoma: CA9 expression serves as a prognostic factor of patients with the cancers as follows: lung cancer [22], breast cancer [23–25], nasopharyngeal cancer [26], esophageal cancer [27], brain tumors [28], cervical carcinoma [29], and gastric cancer [30].